跳至主要内容
临床试验/NCT04276389
NCT04276389Unknown不适用

OCT- Versus Angiography-guided Paclitaxel Drug-Coated Balloon Angioplasty in De Novo Coronary Artery After Lesion Preparation With Scoring Balloon - A Prospective Multicenter Cohort Study

Beijing Anzhen Hospital2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2017年8月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
80
试验地点
2
主要终点
Late lumen loss

研究概览

简要总结

OCT allows precise evaluation of intimal injury after lesion preparation and may improve the acute results and long-term outcomes after paclitaxel drug-coated balloon angioplasty. This prospective multicenter cohort study aims to assess the efficacy and safety of OCT- versus angiography-guided paclitaxel drug-coated balloon angioplasty in middle-sized de novo coronary artery after lesion preparation with scoring balloon.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 to 85 years old
  • Patients have ischemic symptoms or evidence of myocardial ischemia (inducible or spontaneous) in the presence of a stenosis of at least 50% in a native coronary artery, including stable angina, unstable angina, or silent ischemia.
  • Reference vessel diameter >2.5 mm, and <4.0 mm.
  • Lesion length of <22 mm
  • Written informed consent

排除标准

  • Myocardial infarction within 4 weeks, including ST-elevation myocardial infarction and non-ST-elevation myocardial infarction
  • Cardiogenic shock (systolic arterial pressure <90mmHg), congestive heart failure (NYHA or Killip≥3)
  • Chronic kidney disease (eGFR <30 ml/min)
  • Lesion length >22 mm, or vessel diameters of <2.5 mm or >4.0 mm
  • Stents covering a major side branch (>2 mm)
  • Left main lesion
  • Graft lesion
  • Aortic-coronary ostial lesion
  • In-stent restenotic lesion
  • Chronic total occlusion
  • Severe calcified lesions.
  • Visible angiographic thrombus
  • Severe comorbidities: eg. malignancy (life expectancy <2 years)

结局指标

主要结局

Late lumen loss

时间窗: 9 months

Evaluated by QCA

次要结局

  • Rate of binary restenosis(9 months)
  • Target lesion failure(9 months)

研究者

发起方
Beijing Anzhen Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Shao-Ping Nie

Professor of Medicine, Director, Emergency & Critical Care Center

Beijing Anzhen Hospital

研究点 (2)

Loading locations...

相似试验